MA51432A - Procédé de préparation d'une amino-pyrimidine et de ses intermédiaires - Google Patents

Procédé de préparation d'une amino-pyrimidine et de ses intermédiaires

Info

Publication number
MA51432A
MA51432A MA051432A MA51432A MA51432A MA 51432 A MA51432 A MA 51432A MA 051432 A MA051432 A MA 051432A MA 51432 A MA51432 A MA 51432A MA 51432 A MA51432 A MA 51432A
Authority
MA
Morocco
Prior art keywords
intermediaries
pyrimidine
amino
preparation
Prior art date
Application number
MA051432A
Other languages
English (en)
Inventor
Tohru Fukuyama
Kevin Lu
Bradley MORGAN
David Morgans
Matthew Peterson
Original Assignee
Cytokinetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytokinetics Inc filed Critical Cytokinetics Inc
Publication of MA51432A publication Critical patent/MA51432A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/20—Preparation of carboxylic acid nitriles by dehydration of carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA051432A 2017-12-26 2018-12-26 Procédé de préparation d'une amino-pyrimidine et de ses intermédiaires MA51432A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762610302P 2017-12-26 2017-12-26

Publications (1)

Publication Number Publication Date
MA51432A true MA51432A (fr) 2020-11-04

Family

ID=67068143

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051432A MA51432A (fr) 2017-12-26 2018-12-26 Procédé de préparation d'une amino-pyrimidine et de ses intermédiaires

Country Status (15)

Country Link
US (1) US11142516B2 (fr)
EP (1) EP3732166A4 (fr)
JP (1) JP7209726B2 (fr)
KR (1) KR20200109314A (fr)
CN (1) CN112236415B (fr)
AU (1) AU2018397684B2 (fr)
BR (1) BR112020013020A2 (fr)
CA (1) CA3087051A1 (fr)
EA (1) EA202091588A1 (fr)
IL (1) IL275655B2 (fr)
MA (1) MA51432A (fr)
MX (1) MX2020006704A (fr)
PH (1) PH12020550983A1 (fr)
SG (1) SG11202006085PA (fr)
WO (1) WO2019133605A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111848423B (zh) * 2019-04-30 2022-10-14 尚科生物医药(上海)有限公司 3-氧代环丁基氨基甲酸叔丁酯的制备方法
EP3990447A1 (fr) * 2019-06-27 2022-05-04 Cytokinetics, Inc. Polymorphes de 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)méthyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide
WO2024064745A1 (fr) * 2022-09-21 2024-03-28 Cytokinetics, Incorporated Synthèse de reldesemtiv

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1753740A2 (fr) * 2004-05-21 2007-02-21 Merck & Co., Inc. Modulateurs heterocycliques et carbocycliques d'amino cyclopentyle de l'activite du recepteur de la chimiokine
EP2481735A1 (fr) * 2007-05-09 2012-08-01 Pfizer Inc. Dérivés hétérocycliques substitués et leur utilisation pharmaceutique et compositions
EP2560488B1 (fr) 2010-04-23 2015-10-28 Cytokinetics, Inc. Aminopyridines et aminotriazines, leurs compositions et leurs procédés d'utilisation
AR081331A1 (es) * 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) * 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
US9987279B2 (en) * 2014-09-09 2018-06-05 Astellas Pharma Inc. Pharmaceutical composition for prevention and/or treatment of urinary incontinence

Also Published As

Publication number Publication date
AU2018397684A1 (en) 2020-07-16
IL275655B1 (en) 2023-03-01
US20210061786A1 (en) 2021-03-04
MX2020006704A (es) 2020-09-14
JP7209726B2 (ja) 2023-01-20
JP2021508702A (ja) 2021-03-11
CA3087051A1 (fr) 2019-07-04
SG11202006085PA (en) 2020-07-29
CN112236415B (zh) 2023-11-14
WO2019133605A1 (fr) 2019-07-04
EA202091588A1 (ru) 2021-01-18
EP3732166A1 (fr) 2020-11-04
IL275655A (en) 2020-08-31
PH12020550983A1 (en) 2021-03-22
BR112020013020A2 (pt) 2020-11-24
AU2018397684B2 (en) 2023-09-07
CN112236415A (zh) 2021-01-15
IL275655B2 (en) 2023-07-01
EP3732166A4 (fr) 2021-09-01
KR20200109314A (ko) 2020-09-22
US11142516B2 (en) 2021-10-12

Similar Documents

Publication Publication Date Title
EP3353841A4 (fr) Procédé de préparation et d'application de composites de carbone-sélénium
EP3447137A4 (fr) Préparation d'enzyme liquide et son procédé de préparation
EP3303413A4 (fr) Procédés de préparation de sugammadex et de ses intermédiaires
EP3421503A4 (fr) Procédé de préparation et de purification de sugammadex
EP3683205A4 (fr) Procédé de préparation d'isocyanate aliphatique
EP3645529A4 (fr) Procédé pour la préparation de lifitegrast et d'intermédiaires de celui-ci
EP3706725A4 (fr) Processus pour la préparation de tapinarof
EP3398982A4 (fr) Procédé de préparation d'un polymère et ses applications
EP2951158A4 (fr) Procédé de préparation d'ivacaftor et de solvates de celui-ci
EP3728241A4 (fr) Procédé de préparation d'opicapone et d'intermédiaires de celui-ci
EP3640302A4 (fr) Composition de silicone et procédé de production de cette dernière
EP3431520A4 (fr) Procédé de préparation d'un copolymère d'oxyméthylène
MA53370A (fr) Procédé et intermédiaires pour la préparation de bilastine
EP3497090A4 (fr) Nouveaux procédés de préparation de dapagliflozine ou de ses solvates ou co-cristaux de celle-ci
EP3481201A4 (fr) Procédés de préparation de 4-alcoxy-3-(acyl ou alkyl)oxypicolinamides
EP3500551A4 (fr) Procédé de préparation de biphényles substitués
EP3511313A4 (fr) Procédé de préparation de 1,3-cyclohexanediméthanol
EP3644335A4 (fr) Procédé de préparation d'un matériau actif d'anode pour pseudo-condensateur
EP3696168A4 (fr) Procédé de préparation de 2-chloro-5-trifluorométhylpyridine
EP3902792A4 (fr) Procédé de préparation d'anthranilamides
EP3415552A4 (fr) Procédé de préparation d'une résine superabsorbante et résine superabsorbante
EP3737685A4 (fr) Procédé de préparation de crisaborole et de ses intermédiaires
EP3505525A4 (fr) Procédé de préparation de rubusoside
MA50124A (fr) Procédé de préparation de tubulysines et d'intermédiaires de celles-ci
EP3744711A4 (fr) Procédé de préparation de mesaconine et d'intermédiaires associés